Power Medical's endoscopic cutter:
This article was originally published in Clinica
Executive Summary
Power Medical Interventions has received 510(k) clearance from the US FDA for its next-generation device for open and endoscopic surgery. Unlike the first-generation device, the i60 Intelligent Surgical Instrument does not require a power console flexible shaft, claimed the Langhorn, Pennsylvania firm. The device is digitally controlled by motors and clinician-feedback technology that have been miniaturised and integrated into the handpiece. The i60 can be used for gastrointestinal, gynaecological, general abdominal and thoracic surgical procedures for resection, transection and anastomosis. It can also be used for open occlusion of the heart's left atrial appendage. The company is modifying the technology to be used in the emerging field of NOTES (natural orifice translumenal endoscopic surgery).
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.